Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Neurocrine Biosciences
This Pfizer run study stopped due to the co-development program for indiplon being terminated between Pfizer and Neurocrine. The study was terminated on 16 November 2006. There were no safety issues leading to the decision to terminate this study.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DSM-IV defined insomnia
DSM-IV defined Major Depression
You may not be if
Current suicidal ideation or behavior
Primary sleep disorder other than insomnia
Clareo Health | Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
